News

Pender Growth Fund Reports Significant Financial Developments

Pender Growth Fund Reports Significant Financial Developments

Financial Overview of Pender Growth Fund

VANCOUVER, British Columbia — Pender Growth Fund Inc. (TSXV: PTF) has recently shared its financial outcomes and key operational updates for the recent quarter. These results highlight both the challenges and opportunities that the Company navigated in its pursuit of growth and value creation for stakeholders.

Current Financial Highlights

The Company reported a net loss of $248,441 during the most recent quarter ending September 30, reflecting a contrast to the net income of $5,815,990 recorded in the same period last year. This shift underlines the fluctuating market conditions impacting investment performance.

For the quarter, net earnings per Class C common share amounted to $0.04, a departure from $0.80 earned per share in the corresponding quarter of the previous year. However, despite these challenges, the total shareholders' equity saw a slight increase to $123,108,963 come September 30, primarily driven by the net income of $1,706,704, which was somewhat offset by repurchases under the Company's Normal Course Issuer Bid (NCIB).

Share Structure and Management Trends

As of September 30, the shareholders’ equity equated to $17.57 per Share, a modest increase from $17.25 at the end of the previous year. The reported number of outstanding shares decreased to 7,005,729, primarily due to share repurchase activities undertaken by the Company.

The Company's investment portfolio remains diverse, with public companies comprising 60.8% and private companies at 39.2%. The net assets distribution reflects a sturdy focus on public entities, indicating a tactical approach towards market dynamics.

Insights on Investment Management

Pender Growth Fund's Management Expense Ratio (MER), excluding performance fees, was noted at 2.55% for the quarter, showing a slight uptick from 2.39% in the same quarter of the previous year. This metric is critical as it encapsulates the operational efficiency of the Company's investment processes.

Market Trends and Economic Context

Throughout the third quarter of 2025, public equity markets exhibited remarkable growth, achieving record highs despite the persistent macroeconomic uncertainties. Canadian indices like the S&P/TSX Composite experienced a robust uptick of 12.7%, while the TSX Small Cap indices rose by 20.9%.

U.S. market performance echoed similar positivity with the S&P 500 Index (in CAD) demonstrating a growth of 10.5%, backed by strong earnings and favorable rate expectations. The environment remains complex with stretched valuations amidst floating inflation rates.

Global M&A Trends Impacting Investments

New data revealed that global mergers and acquisitions are on the rise, recording a year-to-date announcement value of $2.6 trillion—a significant 28% increase compared to the previous year. This surge can be attributed to renewed confidence among corporations and clearer regulatory landscapes, despite a reduction in the number of transactions indicating a cautious approach from businesses.

Pender Growth Fund continues to adapt its investment strategy in light of these trends, maintaining a bottom-up fundamental approach to identify resilient companies poised to thrive under varied economic circumstances.

Portfolio Management and Strategic Decisions

In alignment with its strategic goals, the Company remains committed to share acquisitions under the NCIB, aiming to capitalize on favorable valuation indicators. The most recent NCIB allows for the purchase of up to 587,342 shares, reinforcing the Company's intent to leverage opportunities in a fluctuating market.

About Pender Growth Fund Inc.

Pender Growth Fund Inc. is an asset management firm focused on nurturing long-term capital growth through investments in unique situations, emphasizing small-cap, special situations, and illiquid public and private companies, specifically within the technology sector.

This firm is listed on the TSX Venture Exchange under the symbol “PTF” and provides regular NAV updates on its website, ensuring transparency for its stakeholders.

Contact Information

For inquiries, please reach out to:

Tony Rautava
Corporate Secretary
Pender Growth Fund Inc.
(604) 653-9625
Toll Free: (866) 377-4743

Frequently Asked Questions

What financial results did Pender Growth Fund report?

Pender Growth Fund announced a net loss of $248,441 for the recent quarter, a shift from a net income of $5,815,990 in the previous year.

How does the share price compare to last year?

The shareholders' equity per share increased slightly to $17.57, compared to $17.25 at the end of last year.

What is the current state of the investment portfolio?

The portfolio consists of approximately 60.8% in public companies and 39.2% in private companies, showcasing a diverse holding strategy.

What trends are observed in the market?

Recent data indicates a strong recovery in public equity markets, with significant gains across major indices despite facing macroeconomic challenges.

How is Pender Growth Fund positioning itself for future growth?

The Company is proactively purchasing shares under its NCIB and focusing on identifying companies capable of thriving across various economic climates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 1

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
Veho's Role in Redefining Beauty E-Commerce Delivery

Updated Category News Views 0

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Continue Reading
Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Updated Category News Views 1

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 2

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Agroz's Big Leap: New Supply Deal in Malaysia

Updated Category News Views 1

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 0

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
Wave Kids™ Unveils New Flavors for Kids' Drinks

Updated Category News Views 1

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...

Continue Reading
EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Updated Category News Views 1

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 4

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
Midlife ADHD in Women: New Challenges and Solutions

Updated Category News Views 0

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

Continue Reading

Top 5 Most Recently Viewed Articles

Allspring Introduces Innovative Equity ETFs to Market

Updated Category News Views 242

Allspring Launches Actively Managed Equity ETFs Allspring Global Investments™, a prominent asset management firm, has made a significant step in investment accessibility by introducing its first active equity exchange-traded funds (ETFs). The two new ETFs, the Allspring LT Large Growth ETF (AGRW) and the Allspring Special Large Value ETF (ASLV), are now trading,...

Continue Reading
Citi's Buy Rating Reinforces Apellis Pharmaceuticals Potential

Updated Category News Views 199

Citi's Position on Apellis Pharmaceuticals Recently, Citi reaffirmed its Buy rating on Apellis Pharmaceuticals (NASDAQ: APLS) with a consistent price target set at $63.00. This positive outlook comes in light of the company's showcase at a prominent nephrology conference, where they unveiled compelling Phase 3 data for pegcetacoplan, aimed at treating C3 glomerulopathy...

Continue Reading
ROLLER Named Among Top Workplaces, Celebrates Culture and Growth

Updated Category News Views 356

ROLLER Shines on the Best Places to Work List ROLLER is dedicated to creating joyful experiences, connecting attractions with easy-to-use technology. This commitment drives their success as a leading venue management platform in the leisure and attractions industry. Acknowledgment of Excellence Recently, ROLLER was named a finalist on the Australian Financial Review's...

Continue Reading
Justin Daley Joins Nevada King Gold as VP of Exploration

Updated Category News Views 185

Nevada King Appoints Justin Daley as Vice President of Exploration Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) proudly announces the appointment of Justin Daley as its new Vice President of Exploration. This strategic addition to Nevada King’s leadership team shows the company’s commitment to advancing mineral exploration. Justin's role is effective immediately...

Continue Reading
TNL Mediagene Partners with Geniee for Innovative Advertising Solutions

Updated Category News Views 168

TNL Mediagene Collaborates with Geniee to Revolutionize Advertising TNL Mediagene has announced a significant strategic partnership with Geniee, a prominent AdTech company based in Japan. This alliance aims to broaden the reach and effectiveness of the advertising creative solution known as Cr.ED. This partnership marks a pivotal moment in the digital advertising...

Continue Reading